Recent Securities Litigations

Enochian Biosciences Inc. Common Stock (NASDAQ: ENOB)

48 Days left to seek lead plaintiff status.

Company Name:Enochian Biosciences Inc. Common Stock
Stock Symbol:NASDAQ: ENOB
Class Period Start:01/17/2018
Class Period End (inclusive):06/27/2022
Filing Deadline:09/26/2022

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Enochian's co-founder was not a licensed doctor and had no verifiable degrees beyond high school; (ii) accordingly, the scientific and technological underpinnings of Enochian’s product pipeline, purportedly invented by the co-founder, were dubious at best; (iii) accordingly, the Defendants had significantly overstated the commercial prospects for the Company’s product pipeline; (iv) Enochian’s senior leadership knew the co-founder had a criminal history that included fraud; (v) accordingly, Enochian’s reliance on the co-founder, and its consulting and licensing agreements with G-Tech and SRI, subjected the Company to a heightened risk of reputational and financial harm, as well as threatened the integrity of the Company’s scientific findings; and (vi) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Enochian Biosciences Inc. Common Stock (NASDAQ: ENOB) Claim Form

Name(Required)
Address
Consent(Required)
This field is for validation purposes and should be left unchanged.